Phase I clinical trial with alpha 1,3,5-triglycidyl-s-triazinetrione (NSC-296934)
- 1 December 1981
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 17 (12) , 1263-1266
- https://doi.org/10.1016/0014-2964(81)90006-2
Abstract
No abstract availableThis publication has 3 references indexed in Scilit:
- Antitumoral effect in mice of a new triepoxyde derivative: 1, 3, 5-triglycidyl-S-triazinetrione (NSC 296934)Published by Elsevier ,1980
- Thrombophlebitic Potential of Intravenous Cytotoxic AgentsDrug Intelligence & Clinical Pharmacy, 1977
- Preparation and Properties of the Diastereoisomeric 1,3,5‐Triglycidyl‐s‐triazinetrionesAngewandte Chemie International Edition in English, 1968